Cyagen has built a one-stop service platform for in vivo and in vitro CAR-T cell therapy research. The platform is available to researchers worldwide, which includes scFv sequence screening, CAR molecular design, and full-process services to develop the foundational research for your CAR-T cell therapy.
Leave a reply